PAXTRAVA

Serial Number 97270111
733

Registration Progress

Application Filed
Feb 16, 2022
Under Examination
Jun 20, 2023
Approved for Publication
Apr 25, 2023
Published for Opposition
Apr 25, 2023
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Dec 20, 2025 5 days

Trademark Image

PAXTRAVA

Basic Information

Serial Number
97270111
Filing Date
February 16, 2022
Published for Opposition
April 25, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
733
Status Date
Jun 9, 2025
Application
Pending
Classes
005

Rights Holder

Ocular Therapeutix, Inc.

03
Address
15 Crosby Drive
Bedford, MA 01730

Ownership History

Ocular Therapeutix, Inc.

Original Applicant
03
Bedford, MA

Ocular Therapeutix, Inc.

Owner at Publication
03
Bedford, MA

Legal Representation

Attorney
Matthew P. Hintz, Esq.

USPTO Deadlines

Next Deadline
5 days remaining
NOA E-Mailed - SOU Required
Due Date
December 20, 2025
Extension Available
Until June 20, 2026

Application History

38 events
Date Code Type Description Documents
Sep 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 9, 2025 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 9, 2025 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 9, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 6, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 6, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 13, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 31, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 30, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 30, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 30, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 24, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 24, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 24, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 5, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 1, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 1, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 1, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 20, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 25, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 25, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 5, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 17, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 17, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 17, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 17, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 17, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 2, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 2, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 2, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 30, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 10, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 10, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 10, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 22, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 19, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Punctum plug drug delivery insert sold filled with pharmaceutical preparations for the treatment of eye diseases and conditions; Punctum plug drug delivery insert sold filled with pharmaceutical preparations for the treatment of glaucoma; Punctum plug drug delivery insert sold filled with pharmaceutical preparations for lowering intraocular pressure; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of glaucoma; Pharmaceutical preparations for the treatment of intraocular pressure.

Classification

International Classes
005